[Skip to Content]

Clinical Trials for Cancer Treatment

Cancer TypePrincipal InvestigatorKeyword OR
ClinicalTrials.Gov ID
 

You searched for Category (Lung): 15 trials found.

Click sort in the column header to sort records.
Study TitlePI
A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with unresected Stage I/II, lymph-node negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515)
Read more
Michael D Mix, MD
A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLEMATES Trial
Read more
Jeffrey A Bogart, MD
A071701 - Genomically-Guided Treatment Trial in Brain Metastases
Read more
Mijung Lee, MD
Alliance A081105 - Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Read more
Stephen L Graziano, MD
Alliance A151216 - Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Read more
Stephen L Graziano, MD
ANAM-17-21 - A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ANAMORELIN HCL FOR THE TREATMENT OF MALIGNANCY ASSOCIATED WEIGHT LOSS AND ANOREXIA IN ADULT PATIENTS WITH ADVANCED NONSMALL CELL LUNG CANCER (NSCLC)
Read more
Alina Basnet
EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous NonSmall Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature driven Analysis
Read more
Stephen L Graziano, MD
EA5181: Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Read more
Stephen L Graziano, MD
ECOG E4512 - A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Read more
Stephen L Graziano, MD
IELCART: Initiative for Early Lung Cancer Research on Treatment
Read more
Leslie J Kohman, MD, FACS
NRG-CC003: Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer
Read more
Michael D Mix, MD
NRG-LU002: Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Read more
Michael D Mix, MD
NRG-LU005 - LIMITED STAGE SMALL CELL LUNG CANCER (LS-SCLC): A PHASE II/III RANDOMIZED STUDY OF CHEMORADIATION VERSUS CHEMORADIATION PLUS ATEZOLIZUMAB
Read more
Stephen L Graziano, MD
Pilot study of the safety and feasibility of administering concurrent systemic chemotherapy with accelerated hypofractionated radiation therapy in the treatment of medically inoperable T1b and T2 Non-Small Cell Lung Cancer
Read more
Michael D Mix, MD
S1827: MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Read more
Michael D Mix, MD

Search Again

Top